ginkgolide a has been researched along with oxidopamine in 1 studies
| Studies (ginkgolide a) | Trials (ginkgolide a) | Recent Studies (post-2010) (ginkgolide a) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
|---|---|---|---|---|---|
| 76 | 2 | 42 | 8,630 | 6 | 2,407 |
| Protein | Taxonomy | ginkgolide a (IC50) | oxidopamine (IC50) |
|---|---|---|---|
| Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, WS; Hsieh, DJ; Huang, CY; Ju, DT; Kao, HC; Kuo, CH; Kuo, WW; Liao, SC; Lin, TY; Lin, YJ | 1 |
1 other study(ies) available for ginkgolide a and oxidopamine
| Article | Year |
|---|---|
Ginkgolide A improves the pleiotropic function and reinforces the neuroprotective effects by mesenchymal stem cell-derived exosomes in 6-OHDA-induced cell model of Parkinson's disease.
Topics: alpha-Synuclein; Dopamine; Exosomes; Humans; Mesenchymal Stem Cells; Neuroprotective Agents; Oxidopamine; Parkinson Disease | 2023 |